全球局部麻醉藥物市場規模、佔有率、成長分析、副產品（布比卡因、羅哌卡因）、依應用（注射劑、表面麻醉劑）- 2024-2031 年產業預測

Global Local Anesthesia Drugs Market Size, Share, Growth Analysis, By Product(Bupivacaine, Ropivacaine), By Application(Injectable, Surface Anesthetic) - Industry Forecast 2024-2031

出版日期: 2024年03月07日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球局部麻醉藥品市場規模為43.4億美元，預計將從2023年的44.9億美元成長到2031年的59.1億美元，預測期間（2024-2031年）複合CAGR為3.5%。

全球局部麻醉藥物市場包括在醫療手術過程中用於暫時麻醉身體特定部位、減輕患者疼痛的藥物。這些藥物透過阻斷目標區域的神經訊號來發揮作用，從而使手術能夠在不引起不適的情況下進行。由於對微創手術的需求不斷增加、更多的人需要慢性病疼痛管理以及更好的藥物配方，該市場不斷成長。該市場的主要參與者是生產各種麻醉藥物（如利多卡因、布比卡因等）的製藥公司。這些藥物可以透過注射、塗在皮膚上或吸入的方式給藥，這取決於手術過程和患者的需要。更多的老年人、更多的醫院外手術以及先進的醫療工具等因素也會影響市場。此外，定製藥物已成為一種趨勢，促使新型藥物及其給藥方式的出現，這有助於市場的成長。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 拉丁美洲其他地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- MEA 的其餘部分

競爭格局

前 5 名玩家比較
2021 年關鍵參與者的市場定位
主要市場參與者所採取的策略
最佳制勝策略
近期市集活動
主要公司市佔率（%），2021年

主要公司簡介

Johnson & Johnson (USA)
Pfizer Inc. (USA)
AstraZeneca plc (UK)
Novartis AG (Switzerland)
Teva Pharmaceutical Industries Ltd. (Israel)
GlaxoSmithKline plc (UK)
Sanofi SA (France)
Merck & Co., Inc. (USA)
Aspen Pharmacare Holdings Limited (South Africa)
Mylan NV (USA)
Fresenius SE & Co. KGaA (Germany)
Abbott Laboratories (USA)
Baxter International Inc. (USA)
Daiichi Sankyo Company, Limited (Japan)
Mallinckrodt Pharmaceuticals (USA)
Sun Pharmaceutical Industries Ltd. (India)
Endo International plc (Ireland)
Hikma Pharmaceuticals PLC (Jordan)
Orion Corporation (Finland)
Sandoz International GmbH (Germany)
Wockhardt Ltd. (India)
Mundipharma International Limited (UK)
Perrigo Company plc (Ireland)
Recordati SpA (Italy)
Piramal Enterprises Ltd. (India)

簡介目錄

Product Code: SQMIG35I2205

Global Local Anesthesia Drugs Market size was valued at USD 4.34 billion in 2022 and is poised to grow from USD 4.49 billion in 2023 to USD 5.91 billion by 2031, growing at a CAGR of 3.5% in the forecast period (2024- 2031).

The global market for local anesthesia drugs includes medicines used to temporarily numb specific parts of the body during medical procedures, easing pain for patients. These drugs work by blocking nerve signals in targeted areas, allowing surgeries to be done without causing discomfort. The market has grown due to the increasing demand for less invasive surgeries, more people needing pain management for chronic conditions, and better drug formulations. Major players in this market are pharmaceutical companies making various anesthetic drugs like lidocaine, bupivacaine, and others. These drugs can be given through injections, applied on the skin, or inhaled, depending on the procedure and patient's needs. Factors like more elderly people, more surgeries done outside hospitals, and advanced medical tools also affect the market. Additionally, there's a trend toward customizing medicines, leading to new types of drugs and how they're given, which helps the market grow.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Local Anesthesia Drugs Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Local Anesthesia Drugs Market Segmental Analysis

The global local anesthesia drugs market is segmented on the basis of Product, Application, and region. By Product, the market is segmented into Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine, Other local anesthetics. By Application, the market is segmented into Injectable, Surface Anesthetic. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Local Anesthesia Drugs Market

The rise in surgical procedures, whether small or large, is a major factor pushing the local anesthesia drugs market forward. Local anesthesia is often used to numb a particular part of the body, lessening the need for general anesthesia and its potential risks. With advancements in surgical methods and the introduction of new procedures, there's a growing need for reliable local anesthesia drugs.

Restraints in the Global Local Anesthesia Drugs Market

The local anesthesia drugs market must meet strict rules and undergo thorough approval processes from health authorities. Creating and getting approval for new drugs or versions can take a lot of time and money. These regulatory obstacles may delay the launch of new products, which could hinder innovation and market expansion.

Market Trends of the Global Local Anesthesia Drugs Market

Local anesthesia drugs are frequently employed in a variety of medical procedures, particularly those that are minimally invasive. These procedures are becoming more popular because they offer advantages like quicker recovery, lower chances of complications, and reduced healthcare expenses. With ongoing technological progress making minimally invasive procedures safer and more feasible, the need for local anesthesia drugs to support these procedures is likely on the rise.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Local Anesthesia Drugs Market by Product

Market Overview
Bupivacaine
Ropivacaine
Lidocaine
Chloroprocaine
Prilocaine
Benzocaine
and Other local anesthetics

Global Local Anesthesia Drugs Market by Application

Market Overview
Injectable
Surface Anesthetic

Global Local Anesthesia Drugs Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aspen Pharmacare Holdings Limited (South Africa)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius SE & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Daiichi Sankyo Company, Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mallinckrodt Pharmaceuticals (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endo International plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hikma Pharmaceuticals PLC (Jordan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orion Corporation (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sandoz International GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wockhardt Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mundipharma International Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Perrigo Company plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Recordati S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Piramal Enterprises Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments